An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

Clinical trial NCT00146523 · COMPLETED

Trial details

NCT number: NCT00146523
Sponsor: Corcept Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2005-05-01
Primary completion: 2006-07-01
Enrollment: 247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.